BetterScholar BetterScholar
Title Claps Level Year L/Y
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
43 auth. G. Respondek, C. Kurz, T. Arzberger, Y. Compta, E. Englund, L. Ferguson, E. Gelpí, A. Giese, D. Irwin, W. Meissner, C. Nilsson, Alexander Y. Pantelyat, A. Rajput, J. V. van Swieten, C. Troakes, ... K. Josephs, A. Lang, B. Mollenhauer, U. Müller, J. Whitwell, A. Antonini, K. Bhatia, Y. Bordelon, J. Corvol, C. Colosimo, R. Dodel, M. Grossman, J. Kassubek, F. Krismer, J. Levin, S. Lorenzl, H. Morris, P. Nestor, W. Oertel, G. Rabinovici, J. Rowe, Thilo van Eimeren, G. Wenning, A. Boxer, L. Golbe, I. Litvan, M. Stamelou, G. Höglinger
Progressive supranuclear palsy (PSP) is a neuropathologically defined disease presenting with a broad spectrum of clinical phenotypes.
Progressive supranuclear palsy (PSP) is a neuropathologically defined disease presenting with a broad spectrum of clinical phenotypes.
Published in Movement Disorders
27
 7 2017